{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T14:18:00Z","timestamp":1766067480630},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,9]]},"DOI":"10.7759\/cureus.21054","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T01:14:28Z","timestamp":1641777268000},"source":"Crossref","is-referenced-by-count":9,"title":["Study of Profile of Mucormycosis During the Second Wave of COVID-19 in a Tertiary Care Hospital"],"prefix":"10.7759","author":[{"given":"Sangita","family":"Kamath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilanjan","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tauheed","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok","family":"Sunder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jof6040265","article-title":"Epidemiology and diagnosis of mucormycosis: an update","volume":"6","author":"Skiada A","year":"2020","unstructured":"Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and diagnosis of mucormycosis: an update. J Fungi (Basel). 2020, 6:10.3390\/jof6040265","journal-title":"J Fungi (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.21862","article-title":"Emerging cases of mucormycosis under COVID-19 pandemic in India: misuse of antibiotics","volume":"82","author":"Gupta G","year":"2021","unstructured":"Gupta G, S R, Singh Y, et al.. Emerging cases of mucormycosis under COVID-19 pandemic in India: misuse of antibiotics. Drug Dev Res. 2021, 82:880-2. 10.1002\/ddr.21862","journal-title":"Drug Dev Res"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1111\/j.1439-0507.2001.00656.x","article-title":"Mucormycoses","volume":"44","author":"Eucker J","year":"2001","unstructured":"Eucker J, Sezer O, Graf B, et al.. Mucormycoses. Mycoses. 2001, 44:253-60.","journal-title":"Mycoses"},{"key":"ref4","article-title":"","author":"Sugar AM","year":"2000","unstructured":"Sugar AM. Mandell, Douglas, and Bennett's principles and practice of infectious diseases.. Mandell GL, Bennett JE, Dolin R (ed): Churchill Livingstone, USA; 2000."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/jof7070545","article-title":"Risk factors for fungal co-infections in critically ill COVID-19 patients, with a focus on immunosuppressants","volume":"7","author":"Ezeokoli OT","year":"2021","unstructured":"Ezeokoli OT, Gcilitshana O, Pohl CH. Risk factors for fungal co-infections in critically ill COVID-19 patients, with a focus on immunosuppressants. J Fungi (Basel). 2021, 7:545. 10.3390\/jof7070545","journal-title":"J Fungi (Basel)"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.4103\/tjo.tjo_72_18","article-title":"Central retinal artery occlusion as the presenting manifestation of invasive rhino-orbital-cerebral mucormycosis","volume":"10","author":"Bawankar P","year":"2020","unstructured":"Bawankar P, Lahane S, Pathak P, et al.. Central retinal artery occlusion as the presenting manifestation of invasive rhino-orbital-cerebral mucormycosis. Taiwan J Ophthal. 2020, 10:62-5.","journal-title":"Taiwan J Ophthal"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-4679(99)00053-0","article-title":"Rhinocerebral mucormycosis: a case of a rare, but deadly disease.","volume":"17","author":"Hendrickson RG","year":"1999","unstructured":"Hendrickson RG, Olshaker J, Duckett O. Rhinocerebral mucormycosis: a case of a rare, but deadly disease.. J Emerg Med. 1999, 17:641-5. 10.1016\/S0736-4679(99)00053-0","journal-title":"J Emerg Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3201\/eid2709.210934","article-title":"Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India","volume":"27","author":"Patel A","year":"2021","unstructured":"Patel A, Agarwal R, Rudramurthy SM, et al.. Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India. Emerg Infect Dis. 2021, 27:2349-59. 10.3201\/eid2709.210934","journal-title":"Emerg Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4193\/Rhino14.183","article-title":"Current therapeutic protocols for chronic granulomatous fungal sinusitis","volume":"53","author":"Rupa V","year":"2015","unstructured":"Rupa V, Maheswaran S, Ebenezer J, Mathews SS. Current therapeutic protocols for chronic granulomatous fungal sinusitis. Rhinology. 2015, 53:181-6. 10.4193\/Rhino14.183","journal-title":"Rhinology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/019459988910700606.1","article-title":"Epidemiology and pathogenesis of paranasal sinus mycoses","volume":"107","author":"Chakrabarti A","year":"1992","unstructured":"Chakrabarti A, Sharma SC, Chandler J. Epidemiology and pathogenesis of paranasal sinus mycoses. Otolaryngol Head Neck Surg. 1992, 107:745-50. 10.1177\/019459988910700606.1","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.18231\/2394-6792.2019.0006","article-title":"Fungal rhinosinusitis: a clinicomorphological study in a tertiary institute","volume":"6","author":"Anushuya G","year":"2019","unstructured":"Anushuya G, Chandramohan A, Karkuzhali P, Saraswathi M. Fungal rhinosinusitis: a clinicomorphological study in a tertiary institute. Indian J Pathol Oncol. 2019, 6:35-38. 10.18231\/2394-6792.2019.0006","journal-title":"Indian J Pathol Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India","volume":"15","author":"Singh AK","year":"2021","unstructured":"Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021, 15:102146. 10.1016\/j.dsx.2021.05.019","journal-title":"Diabetes Metab Syndr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports","volume":"25","author":"Jeong W","year":"2019","unstructured":"Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DC, Chen SC. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019, 25:26-34. 10.1016\/j.cmi.2018.07.011","journal-title":"Clin Microbiol Infect"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006408","article-title":"Molecular mechanisms of mucormycosis-The bitter and the sweet","volume":"13","author":"Baldin C","year":"2017","unstructured":"Baldin C, Ibrahim AS. Molecular mechanisms of mucormycosis-The bitter and the sweet. PLoS Pathog. 2017, 13:e1006408. 10.1371\/journal.ppat.1006408","journal-title":"PLoS Pathog"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-004-1103-y","article-title":"Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study","volume":"23","author":"Tortorano AM","year":"2004","unstructured":"Tortorano AM, Peman J, Bernhardt H, et al.. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis. 2004, 23:317-22. 10.1007\/s10096-004-1103-y","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1298","article-title":"A national strategy to diagnose coronavirus disease 2019-associated invasive fungal disease in the intensive care unit","volume":"73","author":"White PL","year":"2021","unstructured":"White PL, Dhillon R, Cordey A, et al.. A national strategy to diagnose coronavirus disease 2019-associated invasive fungal disease in the intensive care unit. Clin Infect Dis. 2021, 73:e1634-44. 10.1093\/cid\/ciaa1298","journal-title":"Clin Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/jof6040286","article-title":"Is the frequency of candidemia increasing in COVID-19 patients receiving corticosteroids?","volume":"6","author":"Riche CV","year":"2020","unstructured":"Riche CV, Cassol R, Pasqualotto AC. Is the frequency of candidemia increasing in COVID-19 patients receiving corticosteroids?. J Fungi (Basel). 2020, 6:286. 10.3390\/jof6040286","journal-title":"J Fungi (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e3283165fd1","article-title":"Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment","volume":"21","author":"Ibrahim AS","year":"2008","unstructured":"Ibrahim AS, Spellberg B, Edwards J Jr. Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment. Curr Opin Infect Dis. 2008, 21:620-5. 10.1097\/QCO.0b013e3283165fd1","journal-title":"Curr Opin Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13353","article-title":"Mucormycosis and COVID-19: an epidemic within a pandemic in India","volume":"64","author":"Selarka L","year":"2021","unstructured":"Selarka L, Sharma S, Saini D, et al.. Mucormycosis and COVID-19: an epidemic within a pandemic in India. Mycoses. 2021, 64:1253-60. 10.1111\/myc.13353","journal-title":"Mycoses"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.supplement_1.s126","article-title":"Mucormycosis","volume":"14","author":"Sugar AM","year":"1992","unstructured":"Sugar AM. Mucormycosis. Clin Infect Dis. 1992, 14:S126-9. 10.1093\/clinids\/14.supplement_1.s126","journal-title":"Clin Infect Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4274\/tjo.82474","article-title":"Rhino-orbital Mucormycosis: Clinical Findings and Treatment Outcomes of Four Cases","volume":"45","author":"Karadeniz U\u011furlu \u015e","year":"2015","unstructured":"Karadeniz U\u011furlu \u015e, Selim S, Kopar A, Songu M. Rhino-orbital Mucormycosis: Clinical Findings and Treatment Outcomes of Four Cases. Turk J Ophthalmol. 2015, 45:169-74. 10.4274\/tjo.82474","journal-title":"Turk J Ophthalmol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-6257(05)80041-4","article-title":"Survival factors in rhino-orbital-cerebral mucormycosis","volume":"39","author":"Yohai RA","year":"1994","unstructured":"Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol. 1994, 39:3-22. 10.1016\/s0039-6257(05)80041-4","journal-title":"Surv Ophthalmol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrnm.2018.01.001","article-title":"Imaging features of rhinocerebral mucormycosis: a study of 43 patients","volume":"49","author":"Therakathu J","year":"2018","unstructured":"Therakathu J, Prabhu S, Irodi A, Sudhakar SV, Yadav VK, Rupa V. Imaging features of rhinocerebral mucormycosis: a study of 43 patients. Egypt J Radiol Nucl Med. 2018, 49:447-52. 10.1016\/j.ejrnm.2018.01.001","journal-title":"Egypt J Radiol Nucl Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.102267","article-title":"COVID-19 associated rhino-orbital-cerebral mucormycosis: an observational study from Eastern India, with special emphasis on neurological spectrum","volume":"15","author":"Dubey S","year":"2021","unstructured":"Dubey S, Mukherjee D, Sarkar P, et al.. COVID-19 associated rhino-orbital-cerebral mucormycosis: an observational study from Eastern India, with special emphasis on neurological spectrum. Diabetes Metab Syndr. 2021, 15:102267. 10.1016\/j.dsx.2021.102267","journal-title":"Diabetes Metab Syndr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215121000992","article-title":"Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum","volume":"135","author":"Sharma S","year":"2021","unstructured":"Sharma S, Grover M, Bhargava S, Samdani S, Kataria T. Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum. J Laryngol Otol. 2021, 135:442-7. 10.1017\/S0022215121000992","journal-title":"J Laryngol Otol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1977.00780270068011","article-title":"Rhinocerebral mucormycosis","volume":"103","author":"Pillsbury HC","year":"1977","unstructured":"Pillsbury HC, Fischer ND. Rhinocerebral mucormycosis. Arch Otolaryngol. 1977, 103:600-4. 10.1001\/archotol.1977.00780270068011","journal-title":"Arch Otolaryngol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1080\/13693780601113733","article-title":"Cure of disseminated zygomycosis with cerebral involvement using high dose liposomal amphotericin B and surgery","volume":"45","author":"Revankar SG","year":"2007","unstructured":"Revankar SG, Hasan MS, Smith JW. Cure of disseminated zygomycosis with cerebral involvement using high dose liposomal amphotericin B and surgery. Med Mycol. 2007, 45:183-5. 10.1080\/13693780601113733","journal-title":"Med Mycol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02987.","article-title":"Lipid formulations of amphotericin B as first-line treatment of zygomycosis","volume":"15","author":"Petrikkos GL.","year":"2009","unstructured":"Petrikkos GL.. Lipid formulations of amphotericin B as first-line treatment of zygomycosis. Clin Microbiol Infect. 2009, 15:87-92. 10.1111\/j.1469-0691.2009.02987.","journal-title":"Clin Microbiol Infect"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_3763_20","article-title":"COVID-19 and orbital mucormycosis","volume":"69","author":"Sarkar S","year":"2021","unstructured":"Sarkar S, Gokhale T, Choudhury SS, Deb AK. COVID-19 and orbital mucormycosis. Indian J Ophthalmol. 2021, 69:1002-4. 10.4103\/ijo.IJO_3763_20","journal-title":"Indian J Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/78995-study-of-profile-of-mucormycosis-during-the-second-wave-of-covid-19-in-a-tertiary-care-hospital","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:44Z","timestamp":1707507704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/78995-study-of-profile-of-mucormycosis-during-the-second-wave-of-covid-19-in-a-tertiary-care-hospital"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,9]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.21054","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,9]]}}}